Navigation Links
Enabling Technologies Consortium (ETC) Issues Request for Information (RFI) Regarding Development of Medium Throughput Personal Reactor Platform
Date:6/1/2016

Parallel chemical reactor technology is used by scientists to test various reaction conditions, evaluate different substrates or reagents, or synthesize multiple analogs all at the same time during development of a drug substance process. This process can be made easier and more robust through the use of commercially available platforms, chosen primarily based upon the synthesis scale required (low vs. high volume), throughput needed (medium vs. high), and the level of training or expertise required (minimal vs. extensive). However, experience with and review of the currently available commercial technology have demonstrated that from all the permutations possible, the choices of suitable commercial platforms tend to be limited to either 1) easy to use high volume, low throughput or 2) complex, low volume, high throughput systems. These two experimental paradigms can be time and material intensive or require specialized staff to operate.

“A constant pressure faced in the pharmaceutical industry is to shorten development timelines without compromising the quality of the drug substance or the amount of data to supporting a robust control strategy in regulatory filings. Having a flexible, easy to use instrument that can be readily and cost effectively deployed to scientists that provides data rich solutions with minimal effort and material is a critical gap to enable this approach” Jason Tedrow, Ph.D. Amgen; Lead of ETC Personal Parallel Reactor team.

As a result of this gap analysis, members of the Enabling Technologies Consortium (ETC) have decided to address what they feel is a significant void in parallel chemical reactor technology – the lack of a simple to use, low volume, cost effective, and medium throughput platform with representative sampling of the solid and liquid components of reaction slurries – through sponsoring a project to collaboratively develop this platform in partnership with a vendor. As a first step in establishing this partnership, ETC has placed an open call to the vendor community by means of a “Request for Information” (RFI) through the ETC website, http://www.etconsortium.org. The purposes of this RFI are to solicit interest from the vendor community in collaborating on this project and allow vendors to learn more about the technology requirements sought by ETC. This information will be used by ETC to further define this project and ultimately select a vendor to partner with through a formal “Request for Proposals” (RFP) process later this year. It is the intention of ETC that upon completion of this project, a new medium throughput personal reactor platform will have been created and made available to the scientific community as a commercialized product.

We invite any vendor who may be interested in this project to participate by downloading the RFI from the ETC website and submitting a response by the June 10, 2016 deadline.

About Enabling Technologies Consortium (ETC): (http://www.etconsortium.org)
The Enabling Technologies Consortium (ETC) is comprised of pharmaceutical and biotechnology companies collaborating on issues related to pharmaceutical chemistry, manufacturing, and control with the goal of identifying, evaluating, developing, and improving scientific tools and techniques that support the efficient development, and manufacturing of pharmaceuticals. The purpose of this consortium is to identify pro-actively high-value opportunities to deliver innovative technologies where the business case is compelling and collaboration with the broader external community is required. For more information please contact the Secretariat at info(at)etconsortium(dot)org.

Read the full story at http://www.prweb.com/releases/2016/06/prweb13452559.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Norgen Biotek Corp. Announces Supply Agreement with Biodesix Enabling the First EML4-ALK Liquid Biopsy Test with Results in 72-Hours
2. Elsevier to Showcase Solutions for Empowering Knowledge, Enabling Action at HIMSS16
3. ‘Wonder of Nanotechnology’ Details Research Enabling Nanoscale Optoelectronic Devices
4. New Equipment Installed: Enabling Continuous Processing Services at GEA Pharma Systems
5. Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home
6. Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
7. BioRap Technologies to Enter Strategic Collaboration With Pfizer Inc. to Research and Develop Novel Immunomodulators
8. Asymmetrex Presents Technologies to Accelerate Gene-Editing Therapeutics Progress
9. Reichert Technologies - Life Sciences Showcasing Phage Display Research and SPR at CHI-PEGS 2016
10. KGI Technology in Space: Technologies Developed in KGI Labs Have Enabled RNA Analysis at the International Space Station
11. HuMurine Technologies Awarded $299,956 Grant from the National Cancer Institute to Evaluate Immunotherapies in “Humanized” Immune System Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... ... , ... Disappearing forests and increased emissions are the main causes of the ... Especially those living in larger cities are affected by air pollution related diseases. , ... pollution-affected countries globally - decided to take action. , “I knew I had to ...
(Date:10/10/2017)... Philadelphia, PA (PRWEB) , ... October 10, 2017 ... ... University City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. ... accept the award for Excellence in Volunteer Experience from US2020. , US2020’s mission ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
(Date:4/18/2017)... April 18, 2017  Socionext Inc., a global expert in SoC-based ... edge server, the M820, which features the company,s hybrid codec technology. ... by Tera Probe, Inc., will be showcased during the upcoming Medtec ... show at the Las Vegas Convention Center ... Click here ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
Breaking Biology News(10 mins):